Targeting the Th17/Treg axis: from immunological insights to therapeutic avenues in atherosclerosis
Zhang Qin, Siqing Chen, Zhe Lyu, Fengyun Zhou, Le Liu, Qi Ai, Zhuo Zeng · 2026
Read Targeting the Th17/Treg axis: from immunological insights to therapeutic avenues in atherosclerosis by Zhang Qin, Siqing Chen, Zhe Lyu, Fengyun Zhou, Le Liu, Qi Ai, Zhuo Zeng (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13603021.txt.
Description
Artery plaque is now read as an immune disorder as much as a fat-storage one. Zhang Qin and co-authors reviewed in 2026 the tug-of-war between two T cell types inside plaques: aggressive Th17 cells and calming regulatory T cells.
What decides a plaque's fate, they argue, is the balance between the two, acting alongside blood flow forces, fat load, and clotting. The review traces how metabolism and gene switches tip that balance, and how its collapse fuels the chronic vessel inflammation behind heart attacks. It then weighs therapies that retune the axis — damping one side or lifting the other — as a strategy to cool plaques down.
Catalog record
| CREATOR | Zhang Qin, Siqing Chen, Zhe Lyu, Fengyun Zhou, Le Liu, Qi Ai, Zhuo Zeng |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 92 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |